Section Arrow
Quote
SNSE.NASDAQ
- Sensei Biotherapeutics Inc
Quotes are at least 15-min delayed:2026/04/15 09:41 EDT
Regular Hours
Last
 28.7
0 (0.00%)
Day High 
29.3 
Prev. Close
28.7 
1-M High
36.0725 
Volume 
2.57K 
Bid
28
Ask
29.18
Day Low
28.7 
Open
29.3 
1-M Low
22.98 
Market Cap 
38.47M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 31.19 
20-SMA 30.32 
50-SMA 25.75 
52-W High 36.76 
52-W Low 5.25 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-16.72/-12.43
Enterprise Value
38.53M
Balance Sheet
Book Value Per Share
13.87
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
IMMPImmutep Limited0.8799+0.5651+179.51%-- 
LIMNLiminatus Pharma Inc0.196+0.0162+9.01%-- 
ALLOAllogene Therapeutics1.885-0.395-17.32%-- 
LNAILunai Bioworks Inc.0.2984-0.0404-11.92%-- 
RVMDRevolution Medicines149.035+2.025+1.38%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Sensei Biotherapeutics Inc is a clinical-stage biotechnology company engaged in the development of therapies targeting cancer through multi-node inhibition of oncogenic pathways. The company's lead program, PIKTOR, is an investigational oral combination therapy designed to inhibit multiple nodes of the PI3K/AKT/mTOR pathway and is being evaluated for the treatment of endometrial and breast cancers. In addition, the company is advancing other pipeline programs targeting tumormetabolism and signaling pathways.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.